...
首页> 外文期刊>The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease >Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi
【24h】

Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi

机译:马拉维一家结核病-艾滋病综合诊所接受或拒绝结核病患者中艾滋病毒服务的原因

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

SETTING: In Malawi, human immunodeficiency virus (HIV) prevalence among newly registered tuberculosis (TB) patients is 60-70%. In 2008, an integrated TB-HIV clinic was established at a central hospital in Zomba. Despite the integration of TB-HIV activities and improved HIV service uptake, unacceptably high proportions of HIV-positive TB patients are still not receiving antiretroviral therapy (ART). OBJECTIVE: To identify factors that motivate or discourage TB patients from accepting HIV services. DESIGN: Retrospective analysis of patients registered for TB treatment (not yet on ART) between April 2008 and March 2009; qualitative interviews of 99 patients on TB treatment. RESULTS: Of 1773 newly registered TB patients who were not already on ART at the time of TB registration, 86% accepted HIV testing and counselling. Among HIV-positive TB patients, 38% started ART during or after anti-tuberculosis treatment. Young adults aged 15-24 years were least likely to initiate ART. Motivation for accepting ART during TB treatment included prospects of regaining good health and longer life, and counselling by health care providers. Barriers to ART uptake included not being offered ART, high CD4 count, drug stockouts and fear of drug toxicities/interactions. CONCLUSION: Several factors that undermine uptake of ART have been highlighted; targeted measures urgently need to be addressed by TB-HIV programmes to overcome these barriers.
机译:地点:在马拉维,新登记的结核病(TB)患者中人类免疫缺陷病毒(HIV)的患病率为60-70%。 2008年,在Zomba的一家中央医院建立了一个综合的TB-HIV诊所。尽管整合了TB-HIV活动并改善了对HIV服务的接受程度,但仍有相当高比例的HIV阳性TB患者仍未接受抗逆转录病毒疗法(ART)。目的:确定促使或劝阻结核病患者接受艾滋病毒服务的因素。设计:回顾性分析2008年4月至2009年3月期间接受结核病治疗(尚未接受抗逆转录病毒治疗)的患者;对99名结核病患者进行定性访谈。结果:在1773名在结核病登记时尚未接受抗逆转录病毒治疗的新登记结核病患者中,有86%接受了HIV检测和咨询。在HIV阳性结核病患者中,有38%在抗结核治疗期间或之后开始抗病毒治疗。 15-24岁的年轻人最不可能发起抗逆转录病毒治疗。在结核病治疗期间接受抗逆转录病毒治疗的动机包括恢复健康和延长寿命的前景,以及医疗保健提供者的咨询。接受抗逆转录病毒治疗的障碍包括不能接受抗逆转录病毒治疗,高CD4计数,药物缺货和对药物毒性/相互作用的恐惧。结论:几个因素影响了ART的吸收。结核病-艾滋病规划迫切需要解决有针对性的措施,以克服这些障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号